Tech Company Financing Transactions
CBT Pharmaceuticals Funding Round
CBT Pharmaceuticals, operating out of Pleasanton, secured $9.8 million from OrbiMed and private investors.
Transaction Overview
Company Name
Announced On
8/31/2016
Transaction Type
Venture Equity
Amount
$9,750,000
Round
Series A
Investors
OrbiMed (Lead Investor) (Jonathan Wang)
Proceeds Purpose
This financing allows us to advance two of our four development programs into human clinical trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5976 W. Las Positas Blvd. 208
Pleasanton, CA 94588
USA
Pleasanton, CA 94588
USA
Phone
Website
Email Address
Not Recorded
Overview
CBT Pharmaceuticals is an emerging life sciences oncology company focused on developing innovative medicines targeting the growth and proliferation of cancer cells for which available treatments are inadequate.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sanjeev Redkar
Chief Operating Officer
Gavin Choy
VP - Regulatory Affairs
Sarath Kanekal
Browse more venture capital transactions:
Prev: 8/31/2016: HelpSocial venture capital transaction
Next: 8/31/2016: Mitra Biotech venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs